APA (7th ed.) Citation

Gruber, L. J., Zirbes-Klingenhäger, J., Hoene, G., Holdorf, F., Leu, M., Laskawi, R., . . . Wolfer, S. (2026). Refusal of Guideline-Recommended Adjuvant Therapy in Oral Squamous Cell Carcinoma Is Associated with Less Favorable Survival Outcomes. Cancers, 18(11), 1795. https://doi.org/10.3390/cancers18111795

Chicago Style (17th ed.) Citation

Gruber, Lennart Johannes, Johanna Zirbes-Klingenhäger, Georg Hoene, Frederik Holdorf, Martin Leu, Rainer Laskawi, Henning Schliephake, and Susanne Wolfer. "Refusal of Guideline-Recommended Adjuvant Therapy in Oral Squamous Cell Carcinoma Is Associated with Less Favorable Survival Outcomes." Cancers 18, no. 11 (2026): 1795. https://doi.org/10.3390/cancers18111795.

MLA (9th ed.) Citation

Gruber, Lennart Johannes, et al. "Refusal of Guideline-Recommended Adjuvant Therapy in Oral Squamous Cell Carcinoma Is Associated with Less Favorable Survival Outcomes." Cancers, vol. 18, no. 11, 2026, p. 1795, https://doi.org/10.3390/cancers18111795.